12

Chahal P, Baron TH, Petersen BT, Topazian MD, Gostout CJ, Levy MJ. Pancreatic stent prophylaxis of post endoscopic retrograde cholangiopancreatography pancreatitis: spontaneous migration rates and clinical outcomes. Minerva Gastroenterol Dietol 2007; 53(3):225-30. [More details]

11

Mahnke D, Chen YK, Antillon MR, Brown WR, Mattison R, Shah RJ. A prospective study of complications of endoscopic retrograde cholangiopancreatography and endoscopic ultrasound in an ambulatory endoscopy center. Clin Gastroenterol Hepatol 2006; 4(7):924-30. [More details]

10

Brackbill S, Young S, Schoenfeld P, Elta G. A survey of physician practices on prophylactic pancreatic stents. Gastrointest Endosc 2006; 64(1):45-52. [More details]

9

Testoni PA, Mariani A, Masci E, Curioni S. Frequency of post-ERCP pancreatitis in a single tertiary referral centre without and with routine prophylaxis with gabexate: a 6-year survey and cost-effectiveness analysis. Dig Liver Dis 2006; 38(8):588-95. [More details]

8

Kaffes AJ, Bourke MJ, Ding S, Alrubaie A, Kwan V, Williams SJ. A prospective, randomized, placebo-controlled trial of transdermal glyceryl trinitrate in ERCP: effects on technical success and post-ERCP pancreatitis. Gastrointest Endosc 2006; 64(3):351-7. [More details]

7

Testoni PA. Facts and fiction in the pharmacologic prevention of post-ERCP pancreatitis: a never-ending story. Gastrointest Endosc 2006; 64(5):732-4. [More details]

6

Xiong GS, Wu SM, Zhang XW, Ge ZZ. Clinical trial of gabexate in the prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis. Braz J Med Biol Res 2006; 39(1):85-90. [More details]

5

Murray WR. Reducing the incidence and severity of post ERCP pancreatitis. Scand J Surg 2005; 94(2):112-6. [More details]

4

Gottumukkala SR. Prevention of post-ERCP pancreatitis: are there any pearls for sale?. Gastroenterology 2004; 127(1):348-50. [More details]

3

Shankar S, vanSonnenberg E, Silverman SG, Tuncali K, Banks PA. Imaging and percutaneous management of acute complicated pancreatitis. Cardiovasc Intervent Radiol 2004; 27(6):567-80. [More details]

2

Testoni PA. Pharmacological Prevention of Post-ERCP Pancreatitis: The Facts and the Fiction. JOP. J Pancreas (Online) 2004; 5(4):171-8. [More details]

1

Lin CK, Lai KH, Chan HH, Tsai WL, Wang EM, Wei MC, et al. Endoscopic balloon dilatation is a safe method in the management of common bile duct stones. Dig Liver Dis 2004; 36(1):68-72. [More details]